Advisory Services for
Company Sale and Divestiture

With our exclusive focus on the healthcare and life science industries, decades of M&A advisory experience, numerous completed transactions, and an extensive global healthcare network, ConAlliance has developed unparalleled and award-winning expertise in successfully executing company transactions.

This expertise is at your disposal. Absolute discretion is paramount throughout the M&A process. For more information about our approach to business sales, we invite you to contact us directly.

 

Advising Private Owners or Shareholders

The sale of a company is a unique event, significant both financially and emotionally for the seller. It can represent the finale of years of effort by its owners and its management. A business sale often entails a demanding period for the owner. Numerous mistakes can occur during the sale process if not conducted professionally and with meticulous care. Therefore, the sales process should be optimally prepared and rigorously and systematically executed by an M&A advisory firm. ConAlliance M&A advisors are experienced in transactions, persistent, quick to implement, and adept at delivering optimal results even under pressure.

It is essential not only to achieve the maximum sale price but also to ensure the sustainable continuation of the entrepreneurial and intangible values created — a lifetime's work. The goal is to achieve the optimal combination of price, payment terms, contractual terms such as representations and warranties, transaction structure, cultural compatibility, and security with the most effective and appropriate investor.

In this way, ConAlliance M&A advisors alleviate the burden on the business owner during the sale process, ensuring the highest possible success for the transaction. With this in mind ConAlliance guides vendors and executive teams through the sale process, bringing to bear widespread experience and judgment to maximize value and enable smooth transitions of ownership. The ConAlliance keys to success are based on our comprehensive and discrete completion of numerous award-winning sales processes throughout the last 25 years.

 

Advising Financial Investors / Private Equity

ConAlliance also advises Private Equity firms on the sale of portfolio companies (secondaries), provided the transaction involves a healthcare company.

 

Further reading:

The approach to company sales

Every company sale is unique. Therefore, the approach for each sell-side project is tailored and largely customized by the award-winning experts of ConAlliance. But let us illustrate the basic standard's:

When advising the sell-side, our initial step is to analyze the company that is to be sold. The results of these analyses, along with the business structure and potential of the company, and many other project-specific information are integrated into the information memorandum. This document serves as a sales prospectus and decision-making foundation for potential acquirers. Comprehensive documentation is essential, as it allows for the assessment of the development potential of the company to be sold and minimizes inquiries during the negotiation phase.

Naturally, we provide a market-oriented business valuation based on recognized economic valuation methods, combined with our extensive healthcare and life science market knowledge and experience.

We begin by analyzing potential buyers who have a strategic interest in the acquisition or who can leverage synergies through it. This includes considering financial investors and private equity investors. It is crucial to ensure in advance that these interested parties will continue and develop the company in alignment with the seller's intentions.

The subsequent steps are determined by the chosen sales strategy and the sales process or procedure. For instance, we differentiate between exclusive negotiations with a single potential buyer, targeted negotiations with a limited number of potential buyers, or a controlled auction.

Following this, we conduct a highly targeted and confidential approach to potential buyers, initially withholding the names of the company and the sellers. Relevant information is only exchanged after the signing of a confidentiality agreement.

During the pre-contractual negotiation phase, we establish the data room, assist with the buyer-side due diligence, and analyze incoming offers using a dedicated scoring model for offer evaluation. The contractual negotiation phase involves coordinating the entire negotiation process, managing renegotiations, creating the memorandum of understanding (MOU), and coordinating with lawyers and advisors, culminating in the final contract signing.

A multitude of components is necessary to establish the required transparency, enhance our client's negotiating position, convince the buyer, and successfully complete the transaction in our client's best interest.

ConAlliance Service Portfolio

ConAlliance's sell-side advisory services include:

  • Executing the sales process prudently and confidentially
  • Developing tailored exit strategies
  • Preparing for the sale and conducting seller due diligence
  • Creating comprehensive sales documentation, including teasers, pitch books, and information memoranda
  • Identifying, approaching, and evaluating potential buyers (strategic and financial)
  • Managing competitive bidding processes to enhance deal value
  • Overseeing buyer communications and negotiations
  • Structuring transactions and developing financing plans
  • Optimizing purchase price and contractual terms, including liabilities and indemnities
  • Facilitating signing, closing, and post-transaction support

Our Specializations

Sale of Medical Technology Companies

Lorem Ipsum

Medical Technology includes devices, systems, and software developed for medicine and healthcare and also medical and healthcare packaging.

More

Sale of Medical and Healthcare Services Companies

Lorem Ipsum

Medical and healthcare services include diagnosis, treatment, prevention, and rehabilitation, provided in settings like hospitals, laboratories, nursing care, and medical practices.

More

Sale of Life Sciences Companies

Lorem Ipsum

Under "Life Sciences" we subsume everything related to pharmaceuticals, genetics, biotechnology, hygiene, logistics and distribution.

More

Quickcontact

Prof. Christian Langbein, LLM

Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references

Günter Carl Hober

Managing Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references

Prof. Dr. Dr. Ulrich Hemel

Partner
+49 (89) 809 53 63- 0
Curriculum vitae & references

Cliff Murphy, MBA

Managing Director United Kingdom
+44 (20) 81 44 36 00
Curriculum vitae & references

Peer-Olof Andersen

Head of Scandinavia
+44 (20) 81 44 36 00
 

Dr. Charlotte Rothmann

Head of the Americas
+1 (312) 38 00 85 0
Curriculum vitae & references

Gun-Woo Kim, MBA

Head of East-Asia
+852 8197 90 20
 

Quicklinks

Back to top
Find a contact person

Are you interested in selling a healthcare company?

ConAlliance is the expert in healthcare mergers and acquisitions.

Do you plan to sell your medical device company?

We are a longstanding leader in advising on the “sell side” of healthcare M&A transactions.

in case of divestiture life science company ConAlliance Investment Banking is the recommended advisor.

Three general forms can be used for the acquisition of a business: (1) a purchase
of the assets of the business, (2) a purchase of the stock of the target
owning the assets, and (3) a statutory merger of the buyer (or an affiliate) with
the target. It is possible to combine several forms so that, for example, some
assets of the business are purchased separately from the stock of the company
that owns the rest of the assets, and a merger occurs immediately thereafter.

 

company sales Pharmaceuticals and drugs

With a proven track record of life science transaction services, on the buy-side and sell-side, ConAlliance has served the European healthcare industry as a specialized investment banking and consulting firm. With outstanding healthcare M&A experience, we are engaged by public and private organizations to sell or divest a business or product line or to conduct comprehensive acquisition searches to help our clients grow by a corporate M&A transaction.

Transaction services, medical devices, m&a, germany

m&a labs laboratories diagnostic company germany

Linde AG a German supplier of industrial gas, said Sunday it plans to acquire Lincare Holdings Inc., a U.S. provider of respiratory therapy, oxygen and other services to patients at home, for about $4.6 billion. Industrial-gas suppliers have been expanding into the growing business of providing services and equipment such as ventilators or oxygen tanks to people with asthma and other diseases who are managing their conditions at home. Lincare, based in Clearwater, Fla., has more than 800,000 customers in 48 states and Canada, according to its website. In a statement, Munich-based Linde said it had submitted a cash offer of $41.50 per common share to acquire Lincare.

divestiture hospital life sciences

M&A consultants healthcare germany

you might be intersted in the following topics:

  • M&A advisory services
  • m&a healthcare
  • mergers & acquisitions healthcare
  • mergers and acquisitions life science
  • mergers acquisitions medical devices
  • pharmaceuticals & biotechnology mergers & acquisitions, M&A
  • healthcare investment banking
  • mergers & acquisitions wound care m&a

M&A consultants healthcare UK

In mergers & Acquisitions and (commercial) due diligence services we deliver outstanding impact on the reputation and success of our clients, in the UK and globally. In pursuing this we contribute to a sustainable and prosperous society.

 

 

ConAlliance assits you, when you plan to

  • divestiture healthcare company,
  • divestiture medical device company, or
  • acquire healthcare company